@Article{
AUTHOR = {Deteșan, Oana Deteșan and Custură, Lucia Mihaela Custură and Kovács, Brigitta Irén Kovács and Schmiedt, Reka Annamaria Schmiedt and Tilinca, Mariana Cornelia Tilinca},
TITLE = {Current Perspectives in MODY Management—A Narrative Review},
JOURNAL = {Timisoara Medical Journal},
VOLUME = {2021},
YEAR = {2021},
NUMBER = {2},
PAGES = {0--0},
URL = {https://www.tmj.ro/article/2021/2/159},
ISSN = {1583-526X},
ABSTRACT = {Maturity-onset diabetes of the young (MODY) is associated with familially inherited monogenic diabetes. It is characterized by genetic mutations leading to pancreatic β-cell dysfunction and subsequent insulin production. Clinical features of MODY include young-onset hyperglycemia associated with a lack of beta cell autoimmunity or insulin resistance. Glucose-lowering agents are the main therapeutic options for MODY. In this review, we have outlined the particular aspects of the most common types of MODY in order to assist clinical practitioners in this field.},
DOI = {10.35995/tmj20210204}
}